Molecular physiology of mammalian glucokinase.

Cellular and Molecular Life Sciences : CMLS
P B Iynedjian

Abstract

The glucokinase (GCK) gene was one of the first candidate genes to be identified as a human "diabetes gene". Subsequently, important advances were made in understanding the impact of GCK in the regulation of glucose metabolism. Structure elucidation by crystallography provided insight into the kinetic properties of GCK. Protein interaction partners of GCK were discovered. Gene expression studies revealed new facets of the tissue distribution of GCK, including in the brain, and its regulation by insulin in the liver. Metabolic control analysis coupled to gene overexpression and knockout experiments highlighted the unique impact of GCK as a regulator of glucose metabolism. Human GCK mutants were studied biochemically to understand disease mechanisms. Drug development programs identified small molecule activators of GCK as potential antidiabetics. These advances are summarized here, with the aim of offering an integrated view of the role of GCK in the molecular physiology and medicine of glucose homeostasis.

References

Sep 1, 1978·Archives of Biochemistry and Biophysics·M L CárdenasH Niemeyer
Jul 1, 1977·The Biochemical Journal·A C Storer, A Cornish-Bowden
May 30, 1992·Lancet·A T HattersleyJ S Wainscoat
Oct 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·P B IynedjianC B Newgard
Nov 1, 1968·The American Journal of Physiology·T F WilliamsD M Regen
Oct 14, 1994·Biochemical and Biophysical Research Communications·Y ToyodaJ Okuda
Mar 1, 1994·The Journal of Clinical Investigation·M M ByrneG I Bell
Apr 1, 1994·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·E Van SchaftingenM Veiga da Cunha
Jan 1, 1993·Annual Review of Nutrition·R L PrintzD K Granner
Jul 1, 1993·The Biochemical Journal·P B Iynedjian
Jul 9, 1996·Proceedings of the National Academy of Sciences of the United States of America·T FerreA Valera
Oct 15, 1996·The Journal of Clinical Investigation·G VelhoG I Shulman
Nov 15, 1996·The Journal of Biological Chemistry·P B IynedjianK Nazaryan
Apr 29, 1997·Proceedings of the National Academy of Sciences of the United States of America·H Wang, P B Iynedjian
Sep 5, 1997·The Journal of Biological Chemistry·K D NiswenderM A Magnuson
Nov 5, 1997·The Journal of Biological Chemistry·H Wang, P B Iynedjian
Jan 22, 1998·The New England Journal of Medicine·B GlaserK C Herold
Apr 16, 1998·Biochimica Et Biophysica Acta·M L CárdenasT Ureta
Apr 17, 1999·Molecular and Cellular Biology·M ForetzF Foufelle
Oct 27, 1999·Proceedings of the National Academy of Sciences of the United States of America·M ForetzF Foufelle
Nov 7, 1999·The Journal of Biological Chemistry·F SchuitD Pipeleers
Dec 10, 1999·Proceedings of the National Academy of Sciences of the United States of America·D FarrellyN Hariharan

❮ Previous
Next ❯

Citations

Apr 13, 2010·Nature Genetics·Anna KöttgenCaroline S Fox
Apr 18, 2009·Nature Reviews. Drug Discovery·Franz M Matschinsky
Oct 1, 2010·The Journal of Biological Chemistry·Rebecca A HaeuslerDomenico Accili
Jun 18, 2009·American Journal of Physiology. Endocrinology and Metabolism·Louis Hue, Heinrich Taegtmeyer
Mar 10, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Caroline H DiepHaiyong Han
Sep 18, 2012·PloS One·Jeroen F J BogieJerome J A Hendriks
Apr 18, 2014·PloS One·Magdiel SalgadoMaría de Los Angeles García-Robles
Apr 10, 2014·American Journal of Physiology. Endocrinology and Metabolism·Kiichiro UetaMasakazu Shiota
Jan 29, 2014·BMC Genomics·Jan A MennigenSandrine Skiba-Cassy
Nov 8, 2013·Cellular and Molecular Life Sciences : CMLS·Maaike H Oosterveer, Kristina Schoonjans
Jun 12, 2014·BMC Veterinary Research·Sara Lindbloom-HawleyThomas Schermerhorn
Jun 5, 2014·Nutrition Research Reviews·Stéphane PanseratSergio Polakof
Oct 2, 2009·Canadian Journal of Physiology and Pharmacology·Flavio FranciniMaría L Massa
Apr 6, 2012·Journal of Comparative Physiology. B, Biochemical, Systemic, and Environmental Physiology·Sergio PolakofThomas W Moon
Jul 17, 2013·FEBS Letters·María Luz Cárdenas
Jan 8, 2013·Expert Opinion on Drug Discovery·Jeffrey A Pfefferkorn
Dec 22, 2015·Journal of Medicinal Chemistry·Attila PaczalAndrás Kotschy
Oct 23, 2012·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Tingting GuoHuanran Tan
Apr 23, 2015·European Journal of Human Genetics : EJHG·Michael KorostishevskyGregory Livshits
Jul 7, 2012·Trends in Endocrinology and Metabolism : TEM·Sachin SupalePierre Maechler
Aug 30, 2011·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·Sergio PolakofJosé L Soengas
Sep 13, 2011·Progress in Biophysics and Molecular Biology·Jae-Hyung ParkDae-Kyu Song
Dec 30, 2015·Journal of Molecular Recognition : JMR·Muthuraman PanduranganDoo Hwan Kim
Sep 21, 2010·General and Comparative Endocrinology·Nicole RideauJean Simon

❮ Previous
Next ❯

Methods Mentioned

BETA
X-ray
co-immunoprecipitation
two-hybrid
transfection
electrophoretic mobility
transgenics
gene knock-in

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.